Boehringer Ingelheim, IBM Canada Partner To Integrate Blockchain Into Clinical Trials
Canada based pharmaceutical company Boehringer Ingelheim is collaborating with IBM Canada to explore the use of blockchain technology in clinical trials.
Boehringer Ingelheim is a research-driven pharmaceutical company that aims to improve the health and quality of life of patients.
